Skip to content

A Study on the Efficacy of Transcutaneous Electrical Nerve Stimulation and Thermotherapy for Primary Dysmenorrhea in Female College Students

A Study on the Efficacy of Transcutaneous Electrical Nerve Stimulation and Thermotherapy for Primary Dysmenorrhea in Female College Students

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127447
Enrollment
Unknown
Registered
2026-07-01
Start date
2026-07-03
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea

Interventions

Percutaneous nerve electrical stimulation group:Equipment: COMPEX SP6.0 neuromuscular electrical stimulator (manufactured in Taiwan). Parameters: The built-in fixed program "Pain Management TENS" was
Heat patch group:Product: Medical-grade ultra-thin self-heating patch utilizing iron powder oxidation exothermic technology. It causes no noticeable foreign body sensation and does not interfere with

Sponsors

Beijing Sport University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
17 Years to 28 Years

Inclusion criteria

Inclusion criteria: 1. Female college students aged 17-28; 2. Experienced moderate to severe lower abdominal pain for at least six consecutive menstrual cycles, with a pain score on the VAS scale of 4 or higher (out of 10 points); 3. Had not used hormonal contraceptives for at least 6 months prior to participating in the study; 4. Body Mass Index (BMI) between 18.5 and 29.9; 5. Regular menstrual cycle: 21-35 days; 6. Had not taken pain-relieving drugs or any other drugs for treating dysmenorrhea within 24 hours before treatment; 7. Subjects voluntarily participated in the study and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Secondary dysmenorrhea and/or other gynecological disorders; 2. History of abdominal or pelvic surgeries; 3. Comorbid with other diseases that may cause chronic pelvic pain, as well as having severe liver, kidney, and cardiovascular system diseases; 4. Pregnant or planning to become pregnant; 5. Recently received other treatments related to dysmenorrhea; 6. Drug or alcohol addiction; 7. Lesions or injuries on the abdominal wall skin; 8. Allergic to non-steroidal anti-inflammatory drugs; 9. Professional athletes

Design outcomes

Primary

MeasureTime frame
Visual analogue scale change;Usage of painkillers;Duration of pain relief;Complete pain relief rate;

Secondary

MeasureTime frame
Area under the curve (AUC) formed by VAS scores and time over the 0- to 72-hour period;Patient satisfaction and experience;Safety assessment;Simple Quality of Life Evaluation;Anxiety and depression states;Pain intensity at different time points;Onset time;Time to complete relief;

Countries

China

Contacts

Public ContactLiu Dongsen

Beijing Sport University

persistentforever1@163.com+86 10 6278 3742

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026